215 related articles for article (PubMed ID: 29455924)
1. GEC-ESTRO ACROP recommendations in skin brachytherapy.
Guinot JL; Rembielak A; Perez-Calatayud J; Rodríguez-Villalba S; Skowronek J; Tagliaferri L; Guix B; Gonzalez-Perez V; Valentini V; Kovacs G;
Radiother Oncol; 2018 Mar; 126(3):377-385. PubMed ID: 29455924
[TBL] [Abstract][Full Text] [Related]
2. H&N and Skin (HNS) GEC-ESTRO Working Group critical review of recommendations regarding prescription depth, bolus thickness and maximum dose in skin superficial brachytherapy with flaps and customized moulds.
Gonzalez-Perez V; Rembielak A; Guinot JL; Jaberi R; Lancellotta V; Walter R; Zuchora A; Budrukkar A; Kovács G; Jürgenliemk-Schulz I; Siebert FA; Tagliaferri L
Radiother Oncol; 2022 Oct; 175():122-132. PubMed ID: 36030932
[TBL] [Abstract][Full Text] [Related]
3. ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.
Strnad V; Major T; Polgar C; Lotter M; Guinot JL; Gutierrez-Miguelez C; Galalae R; Van Limbergen E; Guix B; Niehoff P; Lössl K; Hannoun-Levi JM
Radiother Oncol; 2018 Sep; 128(3):411-420. PubMed ID: 29691075
[TBL] [Abstract][Full Text] [Related]
4. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - Improvement by cross sectional imaging based treatment planning and stepping source technology.
Kovács G; Martinez-Monge R; Budrukkar A; Guinot JL; Johansson B; Strnad V; Skowronek J; Rovirosa A; Siebert FA;
Radiother Oncol; 2017 Feb; 122(2):248-254. PubMed ID: 27889184
[TBL] [Abstract][Full Text] [Related]
5. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
6. Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report.
Ouhib Z; Kasper M; Perez Calatayud J; Rodriguez S; Bhatnagar A; Pai S; Strasswimmer J
Brachytherapy; 2015; 14(6):840-58. PubMed ID: 26319367
[TBL] [Abstract][Full Text] [Related]
7. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer.
Kovács G; Pötter R; Loch T; Hammer J; Kolkman-Deurloo IK; de la Rosette JJ; Bertermann H
Radiother Oncol; 2005 Feb; 74(2):137-48. PubMed ID: 15734201
[TBL] [Abstract][Full Text] [Related]
8. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.
Haack S; Pedersen EM; Jespersen SN; Kallehauge JF; Lindegaard JC; Tanderup K
Acta Oncol; 2010 Oct; 49(7):978-83. PubMed ID: 20831485
[TBL] [Abstract][Full Text] [Related]
9. GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy.
Siebert FA; Kirisits C; Hellebust TP; Baltas D; Verhaegen F; Camps S; Pieters B; Kovács G; Thomadsen B
Radiother Oncol; 2020 Jul; 148():51-56. PubMed ID: 32335363
[TBL] [Abstract][Full Text] [Related]
10. GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer.
Stewart AJ; Van Limbergen EJ; Gerard JP; Appelt AL; Verhaegen F; Berbee M; Vuong T; Brooker C; Rockall T; Sun Myint A
Clin Transl Radiat Oncol; 2022 Mar; 33():15-22. PubMed ID: 35243017
[TBL] [Abstract][Full Text] [Related]
11. GEC-ESTRO/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma.
Pieters BR; van der Steen-Banasik E; Smits GA; De Brabandere M; Bossi A; Van Limbergen E
Radiother Oncol; 2017 Mar; 122(3):340-346. PubMed ID: 28049550
[TBL] [Abstract][Full Text] [Related]
12. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
[TBL] [Abstract][Full Text] [Related]
13. Skin CanceR Brachytherapy vs External beam radiation therapy (SCRiBE) meta-analysis.
Zaorsky NG; Lee CT; Zhang E; Galloway TJ
Radiother Oncol; 2018 Mar; 126(3):386-393. PubMed ID: 29370985
[TBL] [Abstract][Full Text] [Related]
14. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
[TBL] [Abstract][Full Text] [Related]
15. GEC-ESTRO ACROP recommendations on calibration and traceability of LE-LDR photon-emitting brachytherapy sources at the hospital level.
Perez-Calatayud J; Ballester F; Carlsson Tedgren Å; Rijnders A; Rivard MJ; Andrássy M; Niatsetski Y; Schneider T; Siebert FA
Radiother Oncol; 2019 Jun; 135():120-129. PubMed ID: 31015157
[TBL] [Abstract][Full Text] [Related]
16. Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM.
Kirisits C; Rivard MJ; Baltas D; Ballester F; De Brabandere M; van der Laarse R; Niatsetski Y; Papagiannis P; Hellebust TP; Perez-Calatayud J; Tanderup K; Venselaar JL; Siebert FA
Radiother Oncol; 2014 Jan; 110(1):199-212. PubMed ID: 24299968
[TBL] [Abstract][Full Text] [Related]
17. GEC-ESTRO ACROP recommendations on calibration and traceability of HE HDR-PDR photon-emitting brachytherapy sources at the hospital level.
Perez-Calatayud J; Ballester F; Carlsson Tedgren Å; DeWerd LA; Papagiannis P; Rivard MJ; Siebert FA; Vijande J
Radiother Oncol; 2022 Nov; 176():108-117. PubMed ID: 36167195
[TBL] [Abstract][Full Text] [Related]
18. Moving toward uniform and evidence-based practice of radiotherapy for management of cervical cancer in Ontario, Canada.
Shahid N; Craig T; Westerland M; Ashworth A; Ang M; D'Souza D; Sankreacha R; Fyles A; Milosevic M; Kong I;
Brachytherapy; 2018; 17(4):660-666. PubMed ID: 29681500
[TBL] [Abstract][Full Text] [Related]
19. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.
Haie-Meder C; Pötter R; Van Limbergen E; Briot E; De Brabandere M; Dimopoulos J; Dumas I; Hellebust TP; Kirisits C; Lang S; Muschitz S; Nevinson J; Nulens A; Petrow P; Wachter-Gerstner N;
Radiother Oncol; 2005 Mar; 74(3):235-45. PubMed ID: 15763303
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]